14 Apr 2010 Aeras and Crucell Announce Start of Phase II TB study in South Africa
12 Apr 2010 Sanofi Pasteur Partners with U.S. Naval Medical Research Center to Advance Development of Travelers’ Diarrhea Vaccine
08 Apr 2010 Inovio Biomedical Completes Enrollment of Cervical Cancer Therapeutic Vaccine Study
07 Apr 2010 Vivalis Achieves Milestone With Glaxosmithkline in the Development of Human Flu Vaccines Based on Eb66
06 Apr 2010 Crucell Announces Collaboration with GlaxoSmithKline Biologicals on Second Generation Malaria Vaccine Candidate
06 Apr 2010 MOLOGEN AG receives funding to develop a DNA vaccine against hepatitis B
05 Apr 2010 Immunovaccine Announces the Publication of DPX-0907 Preclinical Study
31 Mar 2010 Parkinson vaccination: Good start to the spring for AFFiRiS AG
30 Mar 2010 GeoVax Labs Granted Allowance By FDA to Start Phase 1 Clinical Trial For HIV/AIDS Therapeutic Vaccine
29 Mar 2010 NOVAVAX Releases Final Results from its Trivalent Seasonal Influenza Vaccine Phase II Clinical Study in Healthy Adults
29 Mar 2010 Immunovaccine Begins Patient Recruitment for Phase 1 Trial of DPX-0907 Cancer Vaccine
25 Mar 2010 Argos Therapeutics Presents New Phase 2a Data on the Impact of Arcelis HIV Program on Viral Genetic Diversity
24 Mar 2010 NOVAVAX Announces Positive Clinical Results from First Stage of Pivotal Study of 2009 A/H1N1 VLP Pandemic Influenza Vaccine in Mexico
23 Mar 2010 Stimuvax Clinical Program Temporarily Suspended
23 Mar 2010 BioSante Announces Additional Positive Leukemia Vaccine Results and Second FDA Orphan Drug Designation
22 Mar 2010 Vical Secures Funding to Proceed With Phase 1 Trial of H1N1 Pandemic Influenza Vaccine
22 Mar 2010 Advaxis Immunotherapeutic ADXS11-001 Phase 1 Survival Data Extended
22 Mar 2010 Pevion Biotech's PEV7 Vulvovaginal Candidiasis Vaccine Enters Phase I
22 Mar 2010 GlaxoSmithKline Statement on New Information Relating to Manufacture of Rotarix (Rotavirus Vaccine)
18 Mar 2010 Novartis receives approval in the European Union for Menveo, first quadrivalent conjugate vaccine in the EU to help prevent meningococcal disease
18 Mar 2010 Genocea Biosciences Signs Exclusive License Agreement with Children’s Hospital Boston for Novel Streptococcus Pneumoniae Antigens
17 Mar 2010 Study Shows Prevenar 13 Is Immunogenic In Young Children Previously Vaccinated With Prevenar
17 Mar 2010 Nabi Biopharmaceuticals Initiates Second Phase III Study for NicVAX as an Aid to Smoking Cessation and Long-term Abstinence
16 Mar 2010 Dynavax Anticipates Earlier BLA Submission for HEPLISAV(TM)

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up